Tsugumine Shu
Director/Board Member chez I'ROM GROUP CO., LTD.
Fortune : 553 563 $ au 31/03/2024
Profil
Tsugumine Shu is currently the Director & Head-ISEL Bank Promotions at I'rom Group Co., Ltd.
since 2022 and the Director & Vice President at Id Pharma Co., Ltd.
since 2019.
Previously, he held positions as President at Beijing B&m Biotech Co., Ltd.
and Researcher at DNAVEC Research, Inc. Dr. Shu obtained a doctorate degree from Tokyo University of Agriculture & Technology in 1989.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
I'ROM GROUP CO., LTD.
0,36% | 31/03/2023 | 44 351 ( 0,36% ) | 553 563 $ | 31/03/2024 |
Postes actifs de Tsugumine Shu
| Sociétés | Poste | Début |
|---|---|---|
| I'ROM GROUP CO., LTD. | Director/Board Member | 01/07/2016 |
Id Pharma Co., Ltd.
 Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | Director/Board Member | 01/04/2004 |
Anciens postes connus de Tsugumine Shu
| Sociétés | Poste | Fin |
|---|---|---|
Beijing B&m Biotech Co., Ltd.
 Beijing B&m Biotech Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of JSR Corp., Beijing B & m Biotech Co., Ltd. is a private company that provides medical services and tools. The company is based in Beijing, China. | President | - |
| DNAVEC Research, Inc. | Corporate Officer/Principal | - |
Formation de Tsugumine Shu
| Tokyo University of Agriculture & Technology | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| I'ROM GROUP CO., LTD. | Health Services |
| Entreprise privées | 3 |
|---|---|
Id Pharma Co., Ltd.
Id Pharma Co., Ltd. BiotechnologyHealth Technology Id Pharma Co., Ltd. manufactures and sells vaccine and gene therapy. The company utilizes its own vector platforms such as sendai virus vector in its business development, resulting in merits that are not readily available to other bio-companies. It is a workshop where scientists and engineers work together to realize their dreams of improving people's health and conquering incurable diseases by exploiting front-edge bioscience and technologies to their full potential. The firm is also a stage or base where the valuable efforts of its collaborators and supporters will come to big fruition. It believes that the promotion of creative collaborations with worldwide partners using its unique gene transfer technologies are the driving force of rapid and sure creation of valuable products and services. The company was founded on September 5, 2003 by Mamoru Hasegawa and is headquartered in Tsukuba, Japan. | Health Technology |
Beijing B&m Biotech Co., Ltd.
Beijing B&m Biotech Co., Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of JSR Corp., Beijing B & m Biotech Co., Ltd. is a private company that provides medical services and tools. The company is based in Beijing, China. | Electronic Technology |
| DNAVEC Research, Inc. |
